TY - JOUR
T1 - Updated practice guideline for dual-energy X-ray absorptiometry (DXA)
AU - Slart, Riemer H. J. A.
AU - Punda, Marija
AU - Ali, Dalal S.
AU - Bazzocchi, Alberto
AU - Bock, Oliver
AU - Camacho, Pauline
AU - Carey, John J.
AU - Colquhoun, Anita
AU - Compston, Juliet
AU - Engelke, Klaus
AU - Erba, Paola A.
AU - Harvey, Nicholas C.
AU - Krueger, Diane
AU - Lems, Willem F.
AU - Lewiecki, E. Michael
AU - Morgan, Sarah
AU - Moseley, Kendall F.
AU - O’Brien, Christopher
AU - Probyn, Linda
AU - Rhee, Yumie
AU - Richmond, Bradford
AU - Schousboe, John T.
AU - Shuhart, Christopher
AU - Ward, Kate A.
AU - van den Wyngaert, Tim
AU - International Working Group on DXA Best Practices
AU - Zhang-Yin, Jules
AU - Khan, Aliya A.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.
AB - The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.
KW - Dual-energy X-ray absorptiometry (DXA)
KW - Practice guideline
KW - Procedures
UR - https://www.scopus.com/pages/publications/85204718467
U2 - 10.1007/s00259-024-06912-6
DO - 10.1007/s00259-024-06912-6
M3 - Review article
C2 - 39316095
SN - 1619-7070
JO - European journal of nuclear medicine and molecular imaging
JF - European journal of nuclear medicine and molecular imaging
ER -